Skip to main content
SpringerLink
Log in

Do NSAIDs increase the severity of COVID-19?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. International Severe Acute Respiratory and Emerging Infection Consortium-Clinical Characterisation Protocol-United Kingdom

References

  • 1. Drake TM, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology : 7 May 2021. Available from: URL: https://doi.org/10.1016/S2665-9913(21)00104-1

  • 2. Kragholm K, et al. Non-steroidal anti-inflammatory drug use in COVID-19. The Lancet Rheumatology : 7 May 2021. Available from: URL: https://doi.org/10.1016/S2665-9913(21)00144-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Do NSAIDs increase the severity of COVID-19?. Reactions Weekly 1856, 7 (2021). https://doi.org/10.1007/s40278-021-96000-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-96000-7

Search

Navigation